Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 2 » Issue 3

Factors affecting health status in COPD patients with co-morbid anxiety or depression

Authors Minna J Hynninen, Ståle Pallesen, Inger Hilde Nordhus

Published 15 October 2007 Volume 2007:2(3) Pages 323—328

Minna J Hynninen¹, Ståle Pallesen², Inger Hilde Nordhus¹

¹Department of Clinical Psychology, University of Bergen, Norway ²Department of Psychosocial Science, University of Bergen, Norway

Abstract: Health status questionnaires provide standardized measures of patients’ perceptions of the impact of disease on their daily life and well-being. Factors associated with health status were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted with the following measures: The St. George’s Respiratory Questionnaire (SGRQ); the Beck Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometry was not related to health status. Perceptions of poor health as implied by the health status scores were positively associated with symptoms of anxiety and depression, sleep disturbances, and level of daily functioning. There were statistically significant differences between men and women on COPD severity, age, and the BAI scores. The findings emphasize the importance of screening the patients at all stages of disease severity for anxiety, depression, and sleeping problems, in order to provide adequate care for these problems.

Keywords: COPD, health status, health-related quality of life, anxiety, depression, sleep

Download Article [PDF] 

Readers of this article also read:

In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence

Ribot EJ, Gaudet JM, Chen Y, Gilbert KM, Foster PJ

International Journal of Nanomedicine 2014, 9:1731-1739

Published Date: 8 April 2014

Prevalence of drug resistance and culture-positive rate among microorganisms isolated from patients with ocular infections over a 4-year period

Shimizu Y, Toshida H, Honda R, Matsui A, Ohta T, Asada Y, Murakami A

Clinical Ophthalmology 2013, 7:695-702

Published Date: 9 April 2013

The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine

Sudhakar P, Kedar S, Berger JR

Neurobehavioral HIV Medicine 2012, 4:99-111

Published Date: 18 September 2012

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Warnke C, Stüve O, Hartung HP, Fogdell-Hahn A, Kieseier B

Neuropsychiatric Disease and Treatment 2011, 7:519-527

Published Date: 8 September 2011

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab

Richard Kelly, Stephen Richards, Peter Hillmen, et al

Therapeutics and Clinical Risk Management 2009, 5:911-921

Published Date: 18 November 2009

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

M Gabrovska, F Geurs, S Ponette, et al

Hepatic Medicine: Evidence and Research 2009, 1:9-12

Published Date: 30 October 2009

Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis

Troels Herlin

Core Evidence 2009, 4:181-189

Published Date: 7 August 2009